Vijay Kumar
Stock Analyst at Evercore ISI Group
(3.45)
# 960
Out of 4,732 analysts
190
Total ratings
54.05%
Success rate
1.96%
Average return
Main Sectors:
Stocks Rated by Vijay Kumar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JBHT J.B. Hunt Transport Services | Maintains: Outperform | $207 → $202 | $172.45 | +17.14% | 6 | Jan 17, 2025 | |
| MTD Mettler-Toledo International | Upgrades: Outperform | $1,375 → $1,450 | $1,295.43 | +11.93% | 8 | Jan 2, 2025 | |
| NVCR NovoCure | Upgrades: Outperform | $18 → $30 | $26.17 | +14.64% | 11 | Dec 2, 2024 | |
| EXAS Exact Sciences | Maintains: Outperform | $80 → $60 | $51.74 | +15.96% | 3 | Nov 6, 2024 | |
| USB U.S. Bancorp | Maintains: In-Line | $51 → $54 | $48.36 | +11.66% | 4 | Oct 30, 2024 | |
| SYK Stryker | Maintains: Outperform | $380 → $384 | $383.42 | +0.15% | 9 | Oct 30, 2024 | |
| TMO Thermo Fisher | Maintains: Outperform | $630 → $620 | $559.65 | +10.78% | 10 | Oct 24, 2024 | |
| ISRG Intuitive Surgical | Maintains: In-Line | $475 → $490 | $592.64 | -17.32% | 11 | Oct 18, 2024 | |
| BLCO Bausch + Lomb | Upgrades: Outperform | $19 → $25 | $17.36 | +44.01% | 7 | Oct 15, 2024 | |
| ZBH Zimmer Biomet Holdings | Maintains: In-Line | $113 → $110 | $109.56 | +0.40% | 12 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $335 → $355 | $404.00 | -12.13% | 8 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $52 → $56 | $47.56 | +17.75% | 5 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $120 → $160 | $139.61 | +14.60% | 7 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $104 | $88.08 | +18.07% | 4 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $78 → $82 | $69.73 | +17.60% | 12 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $98 → $102 | $84.74 | +20.37% | 3 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $76 → $70 | $69.78 | +0.32% | 10 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $62 → $58 | $46.63 | +24.38% | 3 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $275 → $278 | $238.36 | +16.63% | 2 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $82 → $90 | $98.66 | -8.78% | 5 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $286 → $290 | $237.38 | +22.17% | 6 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $53 → $50 | $52.63 | -5.00% | 5 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $120 → $124 | $113.48 | +9.27% | 10 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $135 → $145 | $147.36 | -1.60% | 2 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $4.5 → $5 | $3.65 | +36.99% | 3 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $46 → $45 | $30.98 | +45.26% | 6 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $28 → $27 | $22.11 | +22.12% | 10 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $195 → $175 | $136.67 | +28.05% | 6 | Jun 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $88 → $125 | $118.39 | +5.58% | 1 | Jan 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $7 | $0.98 | +615.02% | 1 | May 31, 2022 |
J.B. Hunt Transport Services
Jan 17, 2025
Maintains: Outperform
Price Target: $207 → $202
Current: $172.45
Upside: +17.14%
Mettler-Toledo International
Jan 2, 2025
Upgrades: Outperform
Price Target: $1,375 → $1,450
Current: $1,295.43
Upside: +11.93%
NovoCure
Dec 2, 2024
Upgrades: Outperform
Price Target: $18 → $30
Current: $26.17
Upside: +14.64%
Exact Sciences
Nov 6, 2024
Maintains: Outperform
Price Target: $80 → $60
Current: $51.74
Upside: +15.96%
U.S. Bancorp
Oct 30, 2024
Maintains: In-Line
Price Target: $51 → $54
Current: $48.36
Upside: +11.66%
Stryker
Oct 30, 2024
Maintains: Outperform
Price Target: $380 → $384
Current: $383.42
Upside: +0.15%
Thermo Fisher
Oct 24, 2024
Maintains: Outperform
Price Target: $630 → $620
Current: $559.65
Upside: +10.78%
Intuitive Surgical
Oct 18, 2024
Maintains: In-Line
Price Target: $475 → $490
Current: $592.64
Upside: -17.32%
Bausch + Lomb
Oct 15, 2024
Upgrades: Outperform
Price Target: $19 → $25
Current: $17.36
Upside: +44.01%
Zimmer Biomet Holdings
Oct 1, 2024
Maintains: In-Line
Price Target: $113 → $110
Current: $109.56
Upside: +0.40%
Oct 1, 2024
Maintains: In-Line
Price Target: $335 → $355
Current: $404.00
Upside: -12.13%
Oct 1, 2024
Maintains: Outperform
Price Target: $52 → $56
Current: $47.56
Upside: +17.75%
Oct 1, 2024
Maintains: Outperform
Price Target: $120 → $160
Current: $139.61
Upside: +14.60%
Oct 1, 2024
Maintains: Outperform
Price Target: $100 → $104
Current: $88.08
Upside: +18.07%
Oct 1, 2024
Maintains: In-Line
Price Target: $78 → $82
Current: $69.73
Upside: +17.60%
Oct 1, 2024
Maintains: Outperform
Price Target: $98 → $102
Current: $84.74
Upside: +20.37%
Oct 1, 2024
Maintains: In-Line
Price Target: $76 → $70
Current: $69.78
Upside: +0.32%
Oct 1, 2024
Maintains: Outperform
Price Target: $62 → $58
Current: $46.63
Upside: +24.38%
Oct 1, 2024
Maintains: Outperform
Price Target: $275 → $278
Current: $238.36
Upside: +16.63%
Oct 1, 2024
Maintains: Outperform
Price Target: $82 → $90
Current: $98.66
Upside: -8.78%
Oct 1, 2024
Maintains: Outperform
Price Target: $286 → $290
Current: $237.38
Upside: +22.17%
Oct 1, 2024
Maintains: In-Line
Price Target: $53 → $50
Current: $52.63
Upside: -5.00%
Oct 1, 2024
Maintains: Outperform
Price Target: $120 → $124
Current: $113.48
Upside: +9.27%
Oct 1, 2024
Maintains: In-Line
Price Target: $135 → $145
Current: $147.36
Upside: -1.60%
Aug 7, 2024
Maintains: In-Line
Price Target: $4.5 → $5
Current: $3.65
Upside: +36.99%
Jul 2, 2024
Maintains: Outperform
Price Target: $46 → $45
Current: $30.98
Upside: +45.26%
Jul 2, 2024
Maintains: Outperform
Price Target: $28 → $27
Current: $22.11
Upside: +22.12%
Jun 11, 2024
Maintains: Outperform
Price Target: $195 → $175
Current: $136.67
Upside: +28.05%
Jan 4, 2024
Upgrades: Outperform
Price Target: $88 → $125
Current: $118.39
Upside: +5.58%
May 31, 2022
Initiates: Outperform
Price Target: $7
Current: $0.98
Upside: +615.02%